首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Recurrent and de novo diabetic nephropathy in renal allografts.
【24h】

Recurrent and de novo diabetic nephropathy in renal allografts.

机译:肾脏同种异体移植物中的复发性和从头糖尿病性肾病。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Histologic findings of diabetic nephropathy (DN) are observed in allografts of patients with pretransplant (PreTx) diabetes mellitus (DM) and in patients who develop DM posttransplant (PostTx). Patients with allograft biopsies (Bx) were retrospectively studied to determine the incidence of recurrent and de novo DN and to ascertain what, if any, risk factors predispose to histologic DN in either patient population. METHODS: From the renal transplant services at four hospitals from 1992 to 2000, the authors identified all patients with PreTxDM and PostTxDM (n=81). Those with renal biopsies performed >/=18 months PostTx were classified according to the presence or absence of histologic DN (Bx-positive, n=23; Bx-negative, n=35). Patients were then subdivided into four categories-recurrent DN (n=16), de novo DN (n=7), no recurrent DN (n=27), and no de novo DN (n=8)-for analyses. RESULTS: Among these 58 patients, 74.1% had PreTx and 25.9% had PostTx diabetes. Of those with histologic DN, 69.6% were recurrent DN and 30.4% were de novo DN, making de novo DN at least as likely to develop as recurrent DN. After the onset of diabetes in the de novo population, the time to development of histologic DN was similar in the recurrent and the de novo patients (6.68+/-3.86 years vs. 5.90+/-3.13 years, P=0.66) and more rapid than previously reported. Apart from a more frequent family history of hypertension in patients with allograft DN compared with those without allograft DN, known risk factors for the development of native DN did not significantly differ among patients in the four cohorts. Proposed risk factors related to transplantation did not correlate with the development of recurrent or de novo DN. CONCLUSION: Among patients with histologic DN, de novo DN occurred at least as frequently as recurrent DN, and the time to onset of histologically apparent DN was more rapid than previously reported. Neither the usual clinical predictors of DN nor clinical variables related to transplantation clearly distinguished the group with DN from the group without it, potentially implicating novel mechanisms in its pathogenesis.
机译:背景:在移植前(PreTx)糖尿病(DM)患者和移植后DM(PostTx)患者中,观察到了糖尿病性肾病(DN)的组织学发现。对具有同种异体活检(Bx)的患者进行了回顾性研究,以确定复发性和新生DN的发生率,并确定在这两个患者群体中哪些易患组织学DN的危险因素(如有)。方法:从1992年至2000年在四家医院的肾脏移植服务中,作者确定了所有PreTxDM和PostTxDM患者(n = 81)。根据组织学DN的存在或不存在,对进行Tx后≥18个月的肾活检的患者进行分类(Bx阳性,n = 23; Bx阴性,n = 35)。然后将患者分为四类-复发DN(n = 16),从头DN(n = 7),没有复发DN(n = 27)和没有从头DN(n = 8)进行分析。结果:在这58例患者中,有74.1%患有PreTx,25.9%患有PostTx糖尿病。在具有组织学性DN的患者中,有69.6%为复发性DN,有30.4%为从头DN,这使得从头DN至少与复发性DN发生的可能性相同。从头开始患糖尿病后,复发患者和从头开始患者的组织学DN发生时间相似(6.68 +/- 3.86年vs.5.90 +/- 3.13年,P = 0.66)及更多比以前报道的要快。除了同种异体DN患者相比没有同种异体DN的高血压家族病史更为频繁外,在这四个队列中,已知自然人DN发生的危险因素没有显着差异。提议的与移植有关的危险因素与复发性或从头DN的发生无关。结论:在具有组织学性DN的患者中,从头DN的发生频率至少与复发性DN相同,并且出现组织学上明显的DN的时间比以前报道的要快。 DN的常规临床预测指标或与移植相关的临床变量均未明确区分具有DN的组和没有DN的组,这可能暗示了其发病机理的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号